AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE in Zimbabwe
7 products registered with MCAZ — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Nexicure 20mg satchets POWDER/SATCHETS; ORAL | 2026/16.7/7417 | ORANGE HEALTH P/L | active | 5 May 2031 |
| NEXICURE POWDER, SOLUBLE; ORAL | 2026/16.7/7418 | ORANGE HEALTH P/L | active | 5 May 2031 |
| NEXICURE POWDER, SOLUBLE; ORAL | 2026/16.7/7419 | ORANGE HEALTH P/L | active | 5 May 2031 |
| NEXICURE TABLET, COATED; ORAL | 2025/16.7/7150 | ORANGE HEALTH P/L | active | 9 Nov 2030 |
| NEXICURE TABLET, COATED; ORAL | 2025/16.7/7149 | ORANGE HEALTH P/L | active | 9 Nov 2030 |
| TRUSFLUKS 20 TABLET, COATED; ORAL | 2025/16.7/6935 | INNOVATA PHARMACEUTICALS | active | 30 Apr 2030 |
| TRUSFLUKS 40 TABLET, COATED; ORAL | 2025/16.7/6936 | INNOVATA PHARMACEUTICALS | active | 30 Apr 2030 |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 7 registered products containing ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, of which 7 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ESOMEPRAZOLE MAGNESIUM TRIHYDRATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.